Return to Homepage
Promoting Excellence in Education, Research, and Patient Care in the Rapidly Evolving Management of Gastrointestinal Cancer International Society of Gastrointestinal Oncology - Established 2003
About Us Highlights and News Conferences Contact Us
ISGIO 2014
2013 ISGIO Conference
Abstracts
2012 Meeting Review
ISGIO 2011
2010 Meeting Review
2009 Meeting Review
2008 Meeting Review
ISGIO 2007 Meeting Information
Click here for the 2007 registration form
Click here for the ISGIO registration form
Program Abstracts

2013 Gastrointestinal Oncology Conference
October 17-19, 2013 - Arlington, VA

Please click on abstract title to review abstract PDF file (opens in a new window).

Esophageal/Gastric Cancer
DUODENOJEJUNAL ANGLE MALIGNANCY: A REAPPRAISAL
Somprakas Basu, Vijay Kumar Shukla
LOW GRADE PRIMARY DIGESTIVE LYMPHOMAS: ANATOMOCLINICAL STUDY AND THERAPEUTIC RESULTS: ABOUT 47 CASES
Brik.S, Hochlef.M, Boudagga.MZ, Mejri.N, Ezzaairi.F, Chabchoub.I, Gharbi.O, Ben Fatma.L, Ben Ahmed.S
PEDIATRIC GASTROINTESTINAL TUMORS AND THEIR RADIOLOGIC APPEARANCE.
Aman Chauhan, Kenneth Ward
MECHANISMS INVOLVED IN THE DEVELOPMENT OF DUODENAL STUMP FISTULA/LEAKAGE
Ding Lian-An, Niu Dong-Guang, Shao Chang-Chun, Cheng Hong-Gang, Sun Zhen-Qing Zhang Jian-Li
THE CLINICAL APPLICATION OF 18F-FDG PET/CT IN THE DIAGNOSTIC OF GASTRIC CANCERS
Liu Lu-guang, DING Lian-an

STUDY ON RELATIONSHIP BETWEEN CIRCULATING MYOSTATIN AND GASTRIC CARCINOMA ASSOCIATED CACHEXIA  
CAO Shu-cheng*, DING Lian-an, NIU Dong-guang Wang Lin, YAO Ru-yong   

THE STUDY ON APPLICATION OF ENTERAL NUTRITION TO POSTOPERATIVE PATIENTS WITH GASTRIC CANCER
Hou Qing-Meng, Ding Lian-An
SAFETY AND SHORT PROCEDURE TIME USING INSERTION OF SELF EXPANDING METAL STENT IN MALIGNANT ESOPHAGEAL STRICTURE WITHOUT FLUOROSCOPY
J. B. Hong*, C. W. Choi, D. H. Kang, H. W. Kim, S. B. Park, B. J. Song, S. J. Kim
EFFICACY OF ENDOSCOPIC ULTRASONOGRAPHY COMPARED TO CONVENTIONAL ENDOSCOPY FOR TUMOR INVASION DEPTH IN EARLY GASTRIC CANCER
SJ Kim, DH Kang, CW Choi, HW Kim, SB Park, BJ Song
RADIOTHERAPY OF CARCINOMA OESOPHAGUS: AVOIDING OVERLAPPING INVESTIGATIONS AND TAILORING DELIVERY TECHNIQUE IMPROVES PATIENTS’ COMPLIANCE AND REDUCES TREATMENT COST
Ramaiah Vinay Kumar, M.D., Dinesh M Gangaiah, M.S., Dr.Madhu S D, M.D., Pramod K P R, M.D.
INCIDENCE OF RARE HISTOPATHOLOGICAL VARIANTS OF GASTRIC TUMORS - A UNIVERSITY HOSPITAL EXPERIENCE
R.Niranjan(Presenting author) senthil anand,sankar narayanan,anisha ashok,Babu elangovan, J.Thanka ( Prof; Dept; histopathology) Sreenivasan Karuparthi,(Prof: Dept of GI surgery ) Sankar Subramanian.(Prof and HOD Dept of GI surgery) Tnagar, Chennai
ESOPHAGEAL CANCER SURVIVAL IN U.S. ADULTS FROM 1973 TO 2009: A SEER DATABASE ANALYSIS OF TEMPORAL TRENDS, INDEPENDENT PREDICTORS OF MORTALITY AND A NOVEL PROGNOSTIC SCORE
Basile Njei, MD, MPH; John W. Birk, MD, FACG
PATHOLOGICAL COMPLETE RESPONSE AFTER CHEMOTHERAPY WITH S-1, CISPLATIN, AND TRASTUZUMAB IN GASTRIC CANCER: A CASE REPORT.
Yusuke Shimodaira, Akihiro Suzuki, Hisashi Onodera
SURVIVAL IMPACT OF ESOPHAGECTOMY AFTER CHEMORADIATION FOR ADENOCARCINOMA OF THE ESOPHAGUS
Ravi Shridhar MD-PhD, Jessica Freilich MD, Sarah E. Hoffe MD, Khaldoun Almhanna MD, William J Fulp MS, MPH, Binglin Yue, Richard C. Karl MD, FACS, and Kenneth Meredith MD, FACS
A CASE REPORT OF AN EXTRAİNTESTİNAL GIST PRESENTİNG AS A GİANT ABDOMİNOPELVİC TUMOR
Prof. Dr. Cavit ÇÖL
INFLAMMATORY FIBROID POLYP
Chauhan A and Joshi V


Pancreatic Cancer
TARGETED MOLECULAR ROBOTIC NANOSURGERY ERADICATES PANCREATIC CANCER STEM CELLS WITH RADIOFREQUENCY DIELECTRIC HEATING (RFDH)AND SILVER-IMMUNONANOBOTS.
John N Giannios
A PHASE 2, RANDOMIZED TRIAL OF GVAX PANCREAS AND CRS-207 IMMUNOTHERAPY VERSUS GVAX ALONE IN PATIENTS WITH METASTATIC PANCREATIC ADENOCARCINOMA: ONGOING SAFETY AND EFFICACY RESULTS
Dung T. Le, Andrea Wang-Gillam, Vincent Picozzi, Tim Greten, Todd Crocenzi, Gregory Springett, Michael Morse, Herbert Zeh, Deidre Cohen, Robert Fine, Beth Onners, Jennifer Uram, Daniel Laheru, Aimee Murphy, Justin Skoble, Ed Lemmens, John Grous, Thomas Dubensky, Jr., Dirk Brockstedt, Elizabeth M. Jaffee
METASTATIC NON- SMALL CELL LUNG CANCER TO THE LIVER AND PANCREAS
Laurie Matt, MD, MPH; Rajesh Sehgal, MD
POST OPERATIVE COMPLICATION AFTER PANCREATICODUODENECTOMY, A COMPARATIVE STUDY WITH INTERNATIONAL STANDARDS
Dr Shanavas K, Dr Prathapan Valiya Kambrath
NASOGASTRIC DECOMPRESSION IN GASTRECTOMIES- IS IT USEFUL? A RCT.
Dr. Preethi S Shetty, MS, Senior Resident, Dr. Prathapan V.K., MS, MCh, Professor & HOD
RISK FACTORS OF MALIGNANCY IN TROPICAL CHRONIC CALCIFIC PANCREATITIS – RETROSPECTIVE STUDY.
Dr. Preethi S Shetty, MS, Senior Resident, Dr. Prathapan V.K., MS, MCh, Professor & HOD

 

Advanced Colon Cancer
THE ROLE OF SHORT CHAIN FATTY ACIDS IN ANGIOGENESIS
A. Hamad*, RM Day, A.Forbes, A.Burns
A VELOUR POST HOC SUBSET ANALYSIS: PROGNOSTIC GROUPS AND TREATMENT OUTCOMES IN PATIENTS WITH METASTATIC COLORECTAL CANCER (MCRC) TREATED WITH AFLIBERCEPT AND FOLFIRI
Ian Chau, Florence Joulain, Sheikh Usman Iqbal, John Bridgewater
AFLIBERCEPT INHIBITS TUMOR GROWTH MORE EFFECTIVELY THAN BEVACIZUMAB IN PATIENT-DERIVED XENOGRAFT (PDX) MODELS OF COLORECTAL CANCER
M. Chiron, R.G. Bagley, J.R. Pollard, C. Henry, P.K. Mankoo, L. Vincent, C. Geslin, Z. Amalou, N. Baltes, D.A. Bergstrom
BUDGETARY IMPACT OF THE ADDITION OF ZIV-AFLIBERCEPT TO A HEALTH PLAN FORMULARY AS A POST-OXALIPLATIN PROGRESSION BIOLOGIC OPTION FOR TREATING PATIENTS WITH METASTATIC COLORECTAL CANCER
Shelby L. Corman, Mei Xue, Dan Hennessy, Susan Pacconi, Edward Drea, Stephen F. Thompson, Xin Gao
TIME COURSE OF ADVERSE EVENTS IN THE VELOUR TRIAL
David R. Ferry, Paul Ruff, Radek Lakomy, Jana Prausova, Guy A. van Hazel, Vladimir M. Moisyenko, Raghu Vishwanath, Emmanuelle Dochy, Eric Van Cutsem, Teresa Macarulla
IS ENDOSCOPIC COLORECTAL STENTING AS A BRIDGE TO SURGERY REALLY USEFUL FOR MALIGNANT COLONIC OBSTRUCTION?
SJ Kim, HW Kim, DH Kang, CW Choi, SB Park, BJ Song
OBSERVED BENEFIT OF AFLIBERCEPT IN MCRC PATIENTS ≥65 YEARS: RESULTS OF A PRESPECIFIED AGE-BASED ANALYSIS OF THE VELOUR STUDY
Paul Ruff, David R. Ferry, Demetris Papamichael, Radek Lakomy, Jana Prausova, Guy A. van Hazel, Vladimir M. Moisyenko, Karen Soussan-Lazard, Emmanuelle Dochy, Eric Van Cutsem, Teresa Macarulla
AFLIBERCEPT/FOLFIRI VS PLACEBO/FOLFIRI IN METASTATIC COLORECTAL CANCER: POST-HOC ANALYSIS OF SURVIVAL BY PRIOR BEVACIZUMAB USE SUBSEQUENT TO EXCLUSION OF PATIENTS WHO HAD RECURRENCE DURING OR WITHIN 6 MONTHS OF COMPLETING ADJUVANT OXALIPLATIN-BASED THERAPY
Eric Van Cutsem, David Raymond Ferry, Radek Lakomy, Pankaj Bhargava, Jana Prausova, Guy Van Hazel, Vladimir Moiseyenko, Joseph McKendrick, Emmanuelle Boelle, Teresa Macarulla
CLINICAL ASPECTS OF COLORECTAL CANCER PATIENTS AGE 80 AND OVER
Wong L; Wortman K; Song J; Ashley P; Wajima T
 
Hot Topics in Gastrointestinal Oncology
A PILOT STUDY INVESTIGATING THE ABILITY OF ADVANCED BIPOLAR RF DEVICE TO INDUCE BLOOD VESSEL HAEMOSTASIS BY ACTIVATION OF THE COAGULATION PATHWAY
Malaz Elsaddig BSc
 
Localized Adjuvant CRC
CONSERVATIVE APPROACH AFTER RADIOCHEMOTHERAPY IN RECTAL CANCER: A META-ANALYSIS.
Francesco Fiorica, Antonio Stefanelli, Marina Marzola , Marcello Daniele , Simona Ascanelli , Carlo Feo, Gabriele Anania, Resta Giuseppe, Fabrizio Di Benedetto, Fabrizio D’Acapito, Giorgio Verdecchia
NO MAJOR SURGERY APPROACH IN RECTAL CANCER WITH MAJOR REGRESSION: A PHASE II STUDY PROTOTCOL (IRIS STUDY).
Francesco Fiorica , Antonio Stefanelli, Marina Marzola , Marcello Daniele, Simona Ascanelli, Carlo Feo, Gabriele Anania, Resta Giuseppe, Fabrizio Di Benedetto, Fabrizio D’Acapito, Giorgio Verdecchia
SAFETY AND EFFICACY OF LAPAROSCOPIC COLECTOMY ON ELDERLY COLON CANCER PATIENTS: AGE SPECIFIC OUTCOMES OF LAPAROSCOPIC COLECTOMY
Naruhiko Ikoma MD, Osamu Itano MD, PhD, Laura Kreiner MD, Shinichi Fukuhara MD, Yuko Kitagawa MD, PhD, FACS
HOW MUCH CAN WE RELY ON PRE-OPERATIVE CT STAGING IN COLORECTAL CANCER?
Dimitris-Christos Zachariades, Siegfried Wagner
 
Neuroendocrine Tumors (NET)
ABOVE THE STANDARD DOSE OF OCTREOTIDE-LAR IN PATIENTS WITH NEUROENDOCRINE TUMORS (NET)
Jamie Goldman, MD; Matthew H. Kulke, MD; Jonathan R. Strosberg, MD; Lynn Huynh, MPH, MBA, DrPH; Mei Sheng Duh, MPH, ScD; Vaibhav Sahai, MD, MS; Alfred W. Rademaker, PhD; Al B. Benson, MD
 
Hepatobiliary Cancer
PROGNOSIS OF PATIENTS WITH FIBROLAMELLAR HEPATOCELLULAR CARCINOMA VERSUS CONVENTIONAL HEPATOCELLULAR CARCINOMA: A SYSTEMATIC REVIEW AND META-ANALYSIS
Basile Njei, MD, MPH
RECURRENT DISEASE AFTER LIVING DONOR LIVER TRANSPLANTATION: RISK FACTORS, MANAGEMENT AND OUTCOME.
Emad Hamdy Salem, Tarek Ibrahim, Amr Helmy, Hesham Abdeldayem, Maher Osman, Ibrahim Abdelkader
SYSTEMIC THERAPY FOR ADVANCED STAGE HEPATOCELLULAR CARCINOMA – BEYOND SORAFENIB
Steven Alberts, MD MPH
LOCOREGIONAL/LIVER DIRECTED THERAPIES
Karen T. Brown, MD, FSIR
HER2 MAY NOT BE AN INTERESTING TARGET IN BILIARY CANCERS: RESULTS OF AN EARLY PHASE II STUDY WITH LAPATINIB
Joshua Peck, Lai Wei, Mark Zalupski, Bert O'Neil, Miguel Villalona Calero, Tanios Bekaii-Saab
ADJUVANT THERAPY FOR BILIARY CANCER
Jennifer J. Knox, MD, MSc, FRCPC
 
©2013 International Society of Gastrointestinal Oncology